BIO's Comment on Advanced Notice of Proposed Rulemaking Regarding Review of Controls for Certain Emerging Technologies
January 17, 2019
BIO urges the Administration to fully assess the potential impact of export controls on biotechnologies on “the impact on the economy of the United States” and on the sustainability of the U.S.’s global leadership in biotechnology, and pursue them “only to the extent necessary” to ensure national security, in accordance with the ECRA statement of policy for export controls in section 4811(1). Before proposing export controls on specific biotechnologies, the Commerce Department should assess the impact of each potential export control on the health of the biotechnology and life sciences ecosystem by evaluating the impact on domestic research, investment into U.S. companies developing or utilizing those technologies, and their ability to recruit and retain skilled talent necessary to develop or deploy those technologies.
The meeting of global trade ministers at the World Trade Organization’s 13th Ministerial Conference in Abu Dhabi offers an important opportunity to build on and strengthen the open and rules-based international trading system to support better…
The companies and workers represented by the undersigned organizations stepped up to combat the COVID-19 pandemic, investing in and creating hundreds of partnerships at an unprecedented speed and scale to leverage U.S. innovation and manufacturing…
BIO urges the Administration to fully assess the potential impact of export controls on biotechnologies on “the impact on the economy of the United States” and on the sustainability of the U.S.’s global leadership in biotechnology, and pursue them “only to the extent necessary” to ensure national security, in accordance with the ECRA statement of policy for export controls in section 4811(1). Before proposing export controls on specific biotechnologies, the Commerce Department should assess the impact of each potential export control on the health of the biotechnology and life sciences ecosystem by evaluating the impact on domestic research, investment into U.S. companies developing or utilizing those technologies, and their ability to recruit and retain skilled talent necessary to develop or deploy those technologies.